Careers  |  Sign In  |  Register

Latest in Arthritis

Reuters Health • The Doctor's Channel Daily Newscast

Hydroxychloroquine reduces risk of kidney damage in lupus

NEW YORK (Reuters Health) - Long-term treatment of systemic lupus erythematosus (SLE) with hydroxychloroquine, initiated soon after disease onset, is protective against renal damage, according to study findings presented this week at the American College of Rheumatology Annual Scientific Meeting in San...

Reuters Health • The Doctor's Channel Daily Newscast

Tocilizumab effective after anti-TNF therapy fails in rheumatoid arthritis

NEW YORK (Reuters Health) – In combination with methotrexate, tocilizumab, an IL-6 receptor inhibitor, can safely improve the signs and symptoms of rheumatoid arthritis in patients with an inadequate response to anti-tumor necrosis factor (TNF) biologicals, new research shows. “This is the first study...

Reuters Health • The Doctor's Channel Daily Newscast

Most RA patients required orthopedic surgery during pre-biologics era

NEW YORK (Reuters Health) - More than half of a cohort of over 180 patients with rheumatoid arthritis (RA) required orthopedic surgery, and one quarter underwent at least one large joint replacement, during a 2-decade study that took place before anti-TNF agents and other biologic therapies were widely...